info@seagull-health.com
SeagullHealth
语言:
search
new
Side Effects of Lemborexant (Dayvigo)
501
Article source: Seagull Pharmacy
Nov 21, 2025

Lemborexant (Dayvigo) is a new-type orexin receptor antagonist that has shown good efficacy in the treatment of insomnia in adults. Like all prescription medications, a thorough understanding of its potential side effects, serious risks, and precautions for use is crucial for patients when taking the drug.

Side Effects of Lemborexant (Dayvigo)

Most Significant Adverse Reactions

Somnolence is the most common adverse reaction of lemborexant, with an incidence rate of 10%.

This somnolent effect may persist into the next day, impairing daytime alertness and activity ability.

Other Frequently Occurring Side Effects

Headache: The incidence rate is approximately 5.9% in the 5mg dose group.

Nightmares or abnormal dreams: The incidence rate is approximately 2.2% in the 10mg dose group.

Serious Side Effects of Lemborexant (Dayvigo)

Complex Sleep Behaviors

This is one of the most critical serious side effects requiring vigilance, which involves various activities performed by patients while not fully awake.

Sleepwalking and sleep driving.

Preparing and consuming food.

Making phone calls.

Engaging in sexual activity.

These behaviors pose potential dangers, and patients often have no memory of the event process. Once such behaviors occur, the medication must be discontinued immediately and a doctor contacted.

Impairment of Daytime Function

As a central nervous system depressant, lemborexant may impair daytime wakefulness even when used as instructed.

In some patients, this depressant effect may persist for several days after discontinuing the medication.

Special Neurological Symptoms

Sleep paralysis: Approximately 1.6% of patients in the 10mg dose group reported experiencing sleep paralysis, which manifests as an inability to move or speak for several minutes during the transition between sleep and wakefulness.

Hypnagogic/hypnopompic hallucinations: The incidence rate is approximately 0.7%, and patients may experience vivid and distressing perceptual experiences.

Cataplexy-like symptoms: Patients may experience transient leg weakness, lasting from a few seconds to a few minutes, which can occur at night or during the day.

Impact on respiratory function: For patients with pre-existing impaired respiratory function, special caution must be exercised when considering the drug's impact on respiratory function.

Precautions for Lemborexant (Dayvigo)

Medication Timing and Administration Method

Timing of administration: Take the medication only when preparing to go to bed.

Time in bed: Ensure that you can stay in bed for at least 7 hours after taking the medication.

Impact of food: Taking the medication with meals or immediately after meals may delay the time to fall asleep.

Medication Instructions

Take the medication strictly according to the dosage prescribed by the doctor; do not increase the dosage on your own.

Recognize the manifestations of potential serious side effects.

Know when immediate medical attention is required.

Precautions for Daily Activities

Driving safety: Patients taking the 10mg dose must be particularly vigilant about impaired driving ability the next day.

Fall prevention: Especially for elderly patients, somnolence increases the risk of falls.

Machinery operation: Avoid operating dangerous machinery when the effects of the medication have not completely subsided.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Dayvigo(lemborexant)
Dayvigo(lemborexant)
In adult patients with insomnia characterized by difficulties with sleep onset...
WeChat Scan
Free Inquiry
Recommended Articles
What are the Precautions for Taking Lemborexant (Dayvigo)?
Lemborexant (Dayvigo) is a new-type orexin receptor antagonist, providing a novel treatment option for patients with insomnia. The full exertion of the medication's efficacy relies on scientific m...
What are the Indications of Lemborexant (Dayvigo)?
Lemborexant (Dayvigo) is a new-type medication for treating insomnia. As an orexin receptor antagonist, it helps improve sleep by regulating the arousal system in the brain.What are the Indications of...
What Are the Purchase Channels for Dayvigo (Lemborexant)?
Dayvigo (lemborexant) is a novel orexin receptor antagonist used for the treatment of insomnia, and its access channels and medication safety have attracted significant attention.What Are the Purchase...
How to Purchase Selumetinib (Koselugo)
Selumetinib (Koselugo) is a MEK1/2 kinase inhibitor specifically indicated for the treatment of symptomatic, inoperable plexiform neurofibromas (PN) in pediatric patients aged 1 year and older with ne...
How to Purchase Emtricitabine and Tenofovir Alafenamide Tablets (Descovy)
Emtricitabine and Tenofovir Alafenamide Tablets (Descovy) is a fixed-dose combination preparation used for HIV-1 treatment and pre-exposure prophylaxis (PrEP). The standardized access to this medicati...
What Kind of Medication is Emtricitabine and Tenofovir Alafenamide Tablets (Descovy)?
Emtricitabine and Tenofovir Alafenamide Tablets (Descovy) is an innovative fixed-dose combination antiretroviral preparation, composed of Emtricitabine (FTC) and Tenofovir Alafenamide (TAF).What Kind ...
Precautions for Administration of Tenofovir Alafenamide and Emtricitabine Tablets (Descovy)
Tenofovir Alafenamide and Emtricitabine Tablets (Descovy) is a fixed-dose combination preparation composed of emtricitabine and tenofovir alafenamide. It is used for the treatment of HIV-1 infection a...
What Are the Side Effects of Emtricitabine and Tenofovir Alafenamide Tablets (Descovy)?
Emtricitabine and Tenofovir Alafenamide Tablets (Descovy) is a fixed-dose combination preparation containing Emtricitabine (FTC) and Tenofovir Alafenamide (TAF). It is used for the treatment of HIV-1 ...
Related Articles
Dosage and Administration of Dayvigo (Lemborexant)
Dayvigo (lemborexant) is an orexin receptor antagonist that was approved by the U.S. FDA in 2019 for the treatment of insomnia in adults. As a novel sleep-aid medication, it exerts its therapeutic eff...
Side Effects of Lemborexant (Dayvigo)
Lemborexant (Dayvigo) is a new-type orexin receptor antagonist that has shown good efficacy in the treatment of insomnia in adults. Like all prescription medications, a thorough understanding of its p...
What are the Precautions for Taking Lemborexant (Dayvigo)?
Lemborexant (Dayvigo) is a new-type orexin receptor antagonist, providing a novel treatment option for patients with insomnia. The full exertion of the medication's efficacy relies on scientific m...
What are the Indications of Lemborexant (Dayvigo)?
Lemborexant (Dayvigo) is a new-type medication for treating insomnia. As an orexin receptor antagonist, it helps improve sleep by regulating the arousal system in the brain.What are the Indications of...
What Are the Purchase Channels for Dayvigo (Lemborexant)?
Dayvigo (lemborexant) is a novel orexin receptor antagonist used for the treatment of insomnia, and its access channels and medication safety have attracted significant attention.What Are the Purchase...
What Are the Side Effects of Lemborexant (Dayvigo)?
Lemborexant (Dayvigo) is an orexin receptor antagonist used for the treatment of insomnia in adults. Like other medications, it may be accompanied by certain side effects, which need to be alleviated ...
How Effective is Lemborexant (Dayvigo) in Treatment?
Lemborexant (Dayvigo) is a novel orexin receptor antagonist that improves insomnia symptoms by regulating the wakefulness signaling pathway.How Effective is Lemborexant (Dayvigo) in Treatment?Improvem...
Precautions for Lemborexant (Dayvigo) Use
Lemborexant (Dayvigo) is a selective orexin receptor antagonist that exerts its effect by blocking the orexin neuropeptide receptors OX1R and OX2R, which promote wakefulness.Precautions for Lemborexan...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved